These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 19753469

  • 1. The utility of anti-trypomastigote lytic antibodies for determining cure of Trypanosoma cruzi infections in treated patients: an overview and perspectives.
    Krettli AU.
    Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():142-51. PubMed ID: 19753469
    [Abstract] [Full Text] [Related]

  • 2. Use of Trypanosoma cruzi purified glycoprotein (GP57/51) or trypomastigote-shed antigens to assess cure for human Chagas' disease.
    Gazzinelli RT, Galvao LM, Krautz G, Lima PC, Cancado JR, Scharfstein J, Krettli AU.
    Am J Trop Med Hyg; 1993 Nov; 49(5):625-35. PubMed ID: 8250103
    [Abstract] [Full Text] [Related]

  • 3. Innovations in diagnosis and post-therapeutic monitoring of Chagas disease: Simultaneous flow cytometric detection of IgG1 antibodies anti-live amastigote, anti-live trypomastigote, and anti-fixed epimastigote forms of Trypanosoma cruzi.
    Alessio GD, Côrtes DF, Machado de Assis GF, Júnior PA, Ferro EA, Antonelli LR, Teixeira-Carvalho A, Martins-Filho OA, de Lana M.
    J Immunol Methods; 2014 Nov; 413():32-44. PubMed ID: 25064148
    [Abstract] [Full Text] [Related]

  • 4. GPI-anchored glycoconjugates from Trypanosoma cruzi trypomastigotes are recognized by lytic anti-alpha-galactosyl antibodies isolated from patients with chronic Chagas' disease.
    Almeida IC, Ferguson MA, Schenkman S, Travassos LR.
    Braz J Med Biol Res; 1994 Feb; 27(2):443-7. PubMed ID: 8081263
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Glycoconjugates of Trypanosoma cruzi: a 74 kD antigen of trypomastigotes specifically reacts with lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas disease.
    Almeida IC, Krautz GM, Krettli AU, Travassos LR.
    J Clin Lab Anal; 1993 Feb; 7(6):307-16. PubMed ID: 8277354
    [Abstract] [Full Text] [Related]

  • 7. Use of a 24-kilodalton Trypanosoma cruzi recombinant protein to monitor cure of human Chagas' disease.
    Krautz GM, Galvão LM, Cançado JR, Guevara-Espinoza A, Ouaissi A, Krettli AU.
    J Clin Microbiol; 1995 Aug; 33(8):2086-90. PubMed ID: 7559953
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Flow cytometry, a new approach to detect anti-live trypomastigote antibodies and monitor the efficacy of specific treatment in human Chagas' disease.
    Martins-Filho OA, Pereira ME, Carvalho JF, Cançado JR, Brener Z.
    Clin Diagn Lab Immunol; 1995 Sep; 2(5):569-73. PubMed ID: 8548536
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The targets of the lytic antibody response against Trypanosoma cruzi.
    Krautz GM, Kissinger JC, Krettli AU.
    Parasitol Today; 2000 Jan; 16(1):31-4. PubMed ID: 10637586
    [Abstract] [Full Text] [Related]

  • 13. Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.
    Sguassero Y, Cuesta CB, Roberts KN, Hicks E, Comandé D, Ciapponi A, Sosa-Estani S.
    PLoS One; 2015 Jan; 10(10):e0139363. PubMed ID: 26436678
    [Abstract] [Full Text] [Related]

  • 14. Anti-Trypanosoma cruzi and anti-laminin antibodies in chagasic patients after specific treatment.
    Gazzinelli RT, Galvão LM, Cardoso JE, Cançado JR, Krettli AU, Brener Z, Gazzinelli G.
    J Clin Microbiol; 1988 Sep; 26(9):1795-800. PubMed ID: 3141467
    [Abstract] [Full Text] [Related]

  • 15. Lytic antibody titre as a means of assessing cure after treatment of Chagas disease: a 10 years follow-up study.
    Galvao LM, Nunes RM, Cançado JR, Brener Z, Krettli AU.
    Trans R Soc Trop Med Hyg; 1993 Sep; 87(2):220-3. PubMed ID: 8337734
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp.
    Caballero ZC, Sousa OE, Marques WP, Saez-Alquezar A, Umezawa ES.
    Clin Vaccine Immunol; 2007 Aug; 14(8):1045-9. PubMed ID: 17522327
    [Abstract] [Full Text] [Related]

  • 17. Human antibody responses to Trypanosoma cruzi 70-kD heat-shock proteins.
    Krautz GM, Peterson JD, Godsel LM, Krettli AU, Engman DM.
    Am J Trop Med Hyg; 1998 Feb; 58(2):137-43. PubMed ID: 9502594
    [Abstract] [Full Text] [Related]

  • 18. Levels of anti-B13 antibodies over time in a cohort of chronic infected by Trypanosoma cruzi. Its relationship with specific treatment and clinical status.
    Olivera V, Bizai ML, Arias E, Suasnabar S, Bottasso O, Marcipar I, Fabbro D.
    Acta Trop; 2021 Jun; 218():105908. PubMed ID: 33789152
    [Abstract] [Full Text] [Related]

  • 19. Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease.
    Umezawa ES, Shikanai-Yasuda MA, Stolf AM.
    J Clin Lab Anal; 1996 Jun; 10(6):407-13. PubMed ID: 8951611
    [Abstract] [Full Text] [Related]

  • 20. [Cysteine-dependent protease in Trypanosoma cruzi useful for the diagnosis of Chagas disease].
    Alberti Amador E, Fachado Carvajales A, Montalvo AM, Izquierdo Pérez LA, Fonte Galindo L.
    Rev Cubana Med Trop; 1998 Jun; 50(1):75-81. PubMed ID: 9842273
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.